Home › Bayer to Present Data on Multiple Oncology Compounds at the European...
 

Keywords :   


Bayer to Present Data on Multiple Oncology Compounds at the European...

2013-09-17 16:58:01| Chemicals - Topix.net

These data include an oral presentation of a subanalysis from the Phase III trial of sorafenib in patients with radioactive iodine-refractory differentiated thyroid cancer, an oral presentation and posters on the efficacy and safety of regorafenib, which was recently approved by the European Medicines Agency , and posters on additional analyses ... (more)

Tags: the data present multiple

Category:Chemicals

Latest from this category

All news
26.11ROSS VersaMix Multi Shaft Mixers are for Complex Formulations
26.11PPG Completes Sale of Silicas Products Business to QEMETICA
26.11¦nie¿ka Among Leaders of Sustainable Development in Poland
26.11Solvay Unveils Climate and Water Projects in Brazil with HRH Princess Astrid of Belgium
25.11PPG Recognized in Newsweeks Americas Greenest Companies List
25.11Axalta Wins Another Distinguished R&D 100 Award for Innovation
25.11Dunn-Edwards CEO Karl Altergott to Retire, COO Monte Lewis is Successor
25.11Global Market Insights: Auto Refinish Coating Market $17.79 Billion by 2032
Chemicals »
27.11
27.11MTG 4
27.1119
27.11
27.11Y-3
27.11
27.1125th PSA10
27.11REVO9
More »